142KiB, 1200x675, https___cdn.cnn.com_cnnnext_dam_assets_200108214800-coronavirus.jpg
Idea 1 -
This idea is based on the research conducted in Cardiff University. After taking cells infected with coronavirus from a patient we will then test various T-killer cells on it until we find one that attacks only the infected cells and leaves the healthy/uneffected cells unharmed. We can get these T-killer cells from the patients, who have recovered from the coronavirus. The body's immune system does develop cells, capable to combat not only the virus the body has recovered from, but also various of the mutated and resistant to antibiotics descendants of that virus. So there is a big chance that right now there is such a T-killer cell in some of the recovered from coronavirus patients.
Once a T-killer cell that kills coronavirus-infected cells has been found we can start removing proteins from the infected cells one by one (just like they did with the cancer cells, where they used crispr cas9 gene editing) to find out which protein serves as an indicator that the cell has been infected. We will figure that out because, once that protein has been removed, the T-killer cells will become inactive and will stop attacking the infected cells, because they won’t be able to recognize them as infected. Once we figure that out we will know which receptor from the T-killer cell spots that protein. We would then be able to take this receptor and place it on other T-killer cells, making them effective against other coronavirus-infected cells. We would then insert the modified T-killer cells into the patient (obviously after conducting tests first) and hopefully that would help them recover.
The biggest flaw with this idea is that due to the virus mutating some patients may require a T-killer cell with a different receptor, because due to the mutation of the virus the T-killer cells can no longer recognize the cell as infected. If such a thing occurs the procedure would be the exact same.
This idea is based on the research conducted in Cardiff University. After taking cells infected with coronavirus from a patient we will then test various T-killer cells on it until we find one that attacks only the infected cells and leaves the healthy/uneffected cells unharmed. We can get these T-killer cells from the patients, who have recovered from the coronavirus. The body's immune system does develop cells, capable to combat not only the virus the body has recovered from, but also various of the mutated and resistant to antibiotics descendants of that virus. So there is a big chance that right now there is such a T-killer cell in some of the recovered from coronavirus patients.
Once a T-killer cell that kills coronavirus-infected cells has been found we can start removing proteins from the infected cells one by one (just like they did with the cancer cells, where they used crispr cas9 gene editing) to find out which protein serves as an indicator that the cell has been infected. We will figure that out because, once that protein has been removed, the T-killer cells will become inactive and will stop attacking the infected cells, because they won’t be able to recognize them as infected. Once we figure that out we will know which receptor from the T-killer cell spots that protein. We would then be able to take this receptor and place it on other T-killer cells, making them effective against other coronavirus-infected cells. We would then insert the modified T-killer cells into the patient (obviously after conducting tests first) and hopefully that would help them recover.
The biggest flaw with this idea is that due to the virus mutating some patients may require a T-killer cell with a different receptor, because due to the mutation of the virus the T-killer cells can no longer recognize the cell as infected. If such a thing occurs the procedure would be the exact same.
